• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Worldwide Market for Rheumatoid Arthritis and Lupus Treatments ( Autoimmune Disease Markets )

$995.00 – $7,000.00

Clear
SKU: KLI1399498 Categories: Drug Discovery Market Reports, Pharmaceuticals Market Research, Prescription Drugs Market Reports Pages: 180
  • Description
  • Table of Contents
  • Latest reports

Description

Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system, multisystemic tissue, and connective tissues. Although a range of autoimmune conditions carry a low prevalence, combined these diseases amount to a growing medical and economic burden. Additionally, autoimmune diseases are accounting for a growing cause of disability in the United States, Europe and worldwide.

Kalorama’s Worldwide Market for Rheumatoid Arthritis and Lupus Treatments (Autoimmune Disease Markets) is the most comprehensive look at the markets for treatments for these two important diseases in the autoimmune disorder category: rheumatoid arthritis and lupus. As part of its thorough, ground up research– the product of interviews with market experts conducted by an experienced pharmaceutical market analyst, this report includes:

  • Market Size and Forecast for NSAIDs and Biologic Treatments
  • New Products in Development
  • Important Issues and Trends
  • Company Profiles
  • Market Share
  • Regional Revenues Breakout

 

Product Managers, marketing managers, business development executives and investment professionals are among those who will find this report to be a useful resource.

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

Introduction

Scope and Methodology

Size and Growth of the Market

Leading Competitors

CHAPTER TWO: INTRODUCTION

History of the Market

Immune System

Autoimmunity

Genetic Factors

Environmental Factors

Gene Research

Distribution

Technology

Demographics

CHAPTER THREE: MARKETS FOR RHEUMATOID ARTHRITIS

Overview

Description of Rheumatoid Arthritis

Diagnosis

Treatment Guidelines

Economic Impact of Disease

Trends in Insurance and Reimbursement

Description of products

Non-steroid Anti-inflammatory Drugs

Biologic Treatments

Disease Modifying Anti-rheumatic Drugs (DMARDs)

Immunosuppressant and Other Biologic Drugs

New Developments

Market Overview

Market by Product Type

Market by Geographical Region

Competitive Analysis

Corporate Profiles

Abbott Laboratories

Amgen, Inc

Boehringer Ingelheim GmbH

Bristol-Myers Squibb

Centocor, Inc.

Genentech, Inc.

Merck & Company, Inc.

Novartis International AG

Pfizer, Inc.

Schering-Plough Corporation

Wyeth

CHAPTER FOUR: MARKETS FOR LUPUS ERYTHEMATOSUS

Overview

Description of Lupus Erythematosus

Diagnosis

Risk Factors

Treatment Guidelines

Economic Impact of Disease

Trends in Insurance and Reimbursement

Description of products

New Developments

Market Overview

Market by Product Type

Market by Geographical Region

Competitive Analysis

Corporate Profiles

Aspreva Pharmaceuticals Corporation

Bristol-Myers Squibb

Genelabs Technologies, Inc.

Genentech, Inc.

GlaxoSmithKline plc

Human Genome Sciences

La Jolla Pharmaceutical Company

Roche

UCB S.A.

CHAPTER FIVE: TOTAL MARKET SIZE AND FORECAST

Overview

Total Market Size and Forecast

Markets by Segments

Leading Competitors

CHAPTER SIX: LIST OF COMPANIES

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Table 1-1: The World Market for Prescription Rheumatoid Arthritis

and Lupus Treatments, 2004-2011

Figure 1-1: The World Market for Prescription Rheumatoid Arthritis

and Lupus Treatments, 2004-2011

CHAPTER TWO: INTRODUCTION

Table 2-1: World Population by Selected Geographical Region, 2006-2050

Figure 2-1: World Population by Selected Geographical Region, 2006-2050

Table 2-2: Estimated World Population by Age and Geographical Region, 2006

Table 2-2: Estimated World Population by Age and Geographical Region, 2006

CHAPTER THREE: RHEUMATOID ARTHRITIS MARKETS

Table 3-1: World Prevalence of Rheumatoid Arthritis by Region 25

Figure 3-1: World Prevalence of Rheumatoid Arthritis, Percent by Region

Table 3-2: Select Marketed Non-steroidal Anti-inflammatory Drugs

Table 3-3: Selected Prescription Disease Modifying Anti-Rheumatic Drugs

Table 3-4: Selected Prescription Immunosuppressant and Other Biologic Drugs

Table 3-5: New Developments in Rheumatoid Arthritis

Figure 3-2: Number of New Developments for Rheumatoid Arthritis by Development Phase

Table 3-6: The World Market for Prescription Rheumatoid Arthritis Treatments, 2004-2011

Figure 3-3: The World Market for Prescription Rheumatoid Arthritis Treatments, 2004-2011

Table 3-7: The World Market for Prescription Rheumatoid Arthritis Treatments, by Product Type, 2004-2011

Figure 3-4:The World Market for Prescription Rheumatoid Arthritis Treatments, by Product Type, 2004-2011

Figure 3-5: The World Market for Prescription Rheumatoid Arthritis Treatments, by Product Type and Percent Distribution, 2004-2011

Figure 3-6: The World Market for Prescription Rheumatoid Arthritis Treatments, by Percent and Product Type, 2006

Figure 3-7: The World Market for Prescription Rheumatoid Arthritis

Treatments, by Percent and Product Type, 2011

Table 3-8: The World Market for Prescription Rheumatoid Arthritis, by Geographic Region, 2006

Figure 3-8: The World Market for Prescription Rheumatoid Arthritis, by Geographic Region, 2006

Table 3-9: Leading Suppliers’ Shares of the World Market for Prescription Rheumatoid Arthritis Treatments, 2006

Figure 3-9: Leading Suppliers’ Shares of the World Market for Prescription Rheumatoid Arthritis Treatments, 2006

CHAPTER FOUR: LUPUS TREATMENT MARKETS

Table 4-1: World Prevalence of Lupus by Region

Figure 4-1: World Prevalence of Lupus, Percent by Region

Table 4-2: Select Marketed Non-steroidal Anti-inflammatory Drugs

Table 4-3: Selected Corticosteroids, Immunosuppressives and DMARDs

Table 4-4: New Developments in Lupus Erythrematosus

Figure 4-2: Number of New Developments for Lupus Erythrematosus by

Development Phase Table 4-5: The World Market for Prescription Lupus Treatments, 2004-2011

Figure 4-3: The World Market for Prescription Lupus Treatments, 2004-2011

Table 4-6: The World Market for Prescription Lupus Treatments, by Product Type, 2004-2011

Figure 4-4: The World Market for Prescription Lupus Treatments, by Product Type, 2004-2011

Figure 4-5: The World Market for Prescription Lupus Treatments, by Product Type and Percent Distribution, 2004-2011

Figure 4-6:The World Market for Prescription Lupus Treatments, by Percent and Product Type, 2006

Figure 4-7:The World Market for Prescription Lupus Treatments, by Percent and Product Type, 2011

Table 4-7:The World Market for Prescription Lupus Treatments, by Geographic Region, 2006

Figure 4-8:The World Market for Prescription Lupus Treatments, by Geographic Region, 2006

Table 4-8:Estimated Leading Suppliers’ Shares of the World Market for Prescription Lupus Treatments, 2011

Figure 4-9:Estimated Leading Suppliers’ Shares of the World Market for Prescription Lupus Treatments, 2011

CHAPTER FIVE: WORLD MARKET SUMMARY

Table 5-1:The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, 2004-2011

Figure 5-1:The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, 2004-2011

Table 5-2:The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, by Product Type, 2004-2011

Figure 5-3:The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, by Product Type, 2004-2011

Figure 5-4:The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, by Product Type and Percent Distribution, 2004-2011

Figure 5-5:The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, by Percent and Product Type, 2006

Figure 5-6:The World Market for Prescription Rheumatoid Arthritis and Lupus Treatments, by Percent and Product Type, 2011

 

    In Vitro Toxicology Market
    July 19, 2018
    100 Companies in Contract Pharmaceutical Research – White Paper
    March 27, 2018
    Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 8th Edition
    March 20, 2018
    Outsourcing in Drug Discovery, 7th Edition
    April 26, 2016

Related products

  • Placeholder image

    Women’s Health: Worldwide Prescription Drug Markets – 3rd Edition

    $2,812.00 – $5,625.00
  • Placeholder image

    Market for Generic Biologics: Issues, Trends, and Market Potential, The

    $1,500.00 – $3,000.00
  • Placeholder image

    U.S. Market for OTC Diet Aids, The

    $3,000.00 – $6,000.00
  • Placeholder image

    Growth Factor Inhibitors: Markets and Opportunities for a Growing Pipeline

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators,...Prescription Dermatological Drugs: Worldwide Market, 6th Edition
Scroll to top